Who owns ANEBULO PHARMACEUTICALS INC?
- Ticker: ANEB
- CUSIP Number: 034569103
Tip: Access positions for across all investors
Analyze quarterly positions in Anebulo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Anebulo Pharmaceuticals stock
Who bought or sold ANEBULO PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
22NW | 5.4M | $13M | 6% | Dec 2023 |
|
LVW Advisors | 643k | $1.6M | -4% | Dec 2023 |
|
Nantahala Capital Management | 511k | $1.2M | 0% | Dec 2023 |
|
Mangrove Partners | 399k | $1.2M | 0% | Sep 2023 |
|
Ikarian Capital | 158k | $382k | 0% | Dec 2023 |
|
Vanguard Group | 153k | $370k | 585% | Dec 2023 |
|
Tower Research Capital | 21k | $64k | 242% | Sep 2023 |
|
Boothbay Fund Management | 19k | $58k | 10% | Sep 2023 |
|
Landscape Capital Management | 15k | $36k | 100% | Dec 2023 |
|
BlackRock | 4.2k | $13k | -42% | Sep 2023 |
|
ADAR1 Capital Management | 1.2k | $2.9k | 100% | Dec 2023 |
|
Royal Bank of Canada | 71.00 | $0 | 48% | Dec 2023 |
|
Wells Fargo & Company | 61.00 | $147.998200 | 5% | Dec 2023 |
|
Bank of America Corporation | 4.00 | $10.000000 | 100% | Dec 2023 |
|
Who sold out of Anebulo Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Praetorian PR | Sep 2023 | 177k | $542k |